Fetal Mesenchymal Stromal Cells: an Opportunity for Prenatal Cellular Therapy

被引：31

作者：

Sagar R. ^{[1
]}

Walther-Jallow L. ^{[2
]}

David A.L. ^{[1
,3
]}

Götherström C. ^{[2
]}

Westgren M. ^{[2
]}

机构：

[1] Institute for Women’s Health, University College London, 86-96 Chenies Mews, London

[2] Department of Clinical Science, Intervention and Technology, K57, Division of Obstetrics and Gynecology, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm

[3] Katholieke Universiteit Leuven, Oude Markt 13, Leuven

来源：

Current Stem Cell Reports | 2018年 / 4卷 / 1期

关键词：

In utero stem cell transplantation; Mesenchymal stromal cells; Prenatal therapy;

D O I：

10.1007/s40778-018-0118-8

中图分类号：

学科分类号：

摘要：

Purpose of Review: The aim of the study is to provide an overview on the possibility of treating congenital disorders prenatally with mesenchymal stromal cells (MSCs). Recent Findings: MSCs have multilineage potential and a low immunogenic profile and are immunomodulatory and more easy to expand in culture. Their ability to migrate, engraft and differentiate, or act via a paracrine effect on target tissues makes MSCs candidates for clinical therapies. Fetal and extra-fetal MSCs offer higher therapeutic potential compared to MSCs derived from adult sources. Summary: MSCs may be safely transplanted prenatally via ultrasound-guided injection into the umbilical cord. Due to these characteristics, fetal MSCs are of great interest in the field of in utero stem cell transplantation for treatment of congenital disease. © 2018, The Author(s).

引用

页码：61 / 68

页数：7

共 50 条

[1] Human fetal mesenchymal stem cells for intrauterine cellular therapy
Chan, J
O'Donoghue, K
Kennea, N
de la Fuente, J
Waddington, S
Themis, M
Mehmet, H
Watt, D
Morgan, J
Fisk, N
JOURNAL OF GENE MEDICINE, 2004, 6 (09): : S17 - S17
[2] The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis
Auletta, Jeffery J.
Bartholomew, Amelia M.
Maziarz, Richard T.
Deans, Robert J.
Miller, Robert H.
Lazarus, Hillard M.
Cohen, Jeffrey A.
IMMUNOTHERAPY, 2012, 4 (05) : 529 - 547
[3] Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy
Vitali V. Maldonado
Neel H. Patel
Emma E. Smith
C. Lowry Barnes
Michael P. Gustafson
Raj R. Rao
Rebekah M. Samsonraj
Journal of Biological Engineering, 17
[4] Clinical utility of mesenchymal stem/stromal cells in regenerative medicine and cellular therapy
Maldonado, Vitali V.
Patel, Neel H.
Smith, Emma E.
Barnes, C. Lowry
Gustafson, Michael P.
Rao, Raj R.
Samsonraj, Rebekah M.
JOURNAL OF BIOLOGICAL ENGINEERING, 2023, 17 (01)
[5] Safety and efficacy of cellular therapy with mesenchymal stromal cells in sepsis, meta-analysis
Mohammed Debes
Amr Elyasaky
Ramy Elantary
Mohamed Abouzeid
Discover Medicine, 2 (1):
[6] Identification and Characterization of Human Endometrial Mesenchymal Stem/Stromal Cells and Their Potential for Cellular Therapy
Darzi, Saeedeh
Werkmeister, Jerome A.
Deane, James A.
Gargett, Caroline E.
STEM CELLS TRANSLATIONAL MEDICINE, 2016, 5 (09) : 1127 - 1132
[7] How to track cellular aging of mesenchymal stromal cells?
Wagner, Wolfgang
Bork, Simone
Lepperdinger, Guenther
Joussen, Sylvia
Ma, Nan
Strunk, Dirk
Koch, Carmen
AGING-US, 2010, 2 (04): : 224 - 230
[8] The preclinical and clinical implications of fetal adnexa derived mesenchymal stromal cells in wound healing therapy
Mankuzhy, Pratheesh D.
Ramesh, Sreekumar T.
Thirupathi, Yasotha
Mohandas, Ponny S.
Chandra, Vikash
Sharma, Taru Guttula
WOUND REPAIR AND REGENERATION, 2021, 29 (03) : 347 - 369
[9] Manufacturing of primed mesenchymal stromal cells for therapy
James Q. Yin
Jun Zhu
James A. Ankrum
Nature Biomedical Engineering, 2019, 3 : 90 - 104
[10] Pediatric mesenchymal stromal cells therapy: an update
An, Qi
Fan, Conghai
Xu, Shumei
MINERVA PEDIATRICA, 2018, 70 (04) : 396 - 402

← 1 2 3 4 5 →